Cite
HARVARD Citation
Fiedler, W. et al. (2016). A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas. European journal of cancer. pp. 55-63. [Online].